Eye-Link Minnesota
  • Application
  • Resources
  • News
  • Donate
  • Contact
  • Application
  • Resources
  • News
  • Donate
  • Contact

Gene Therapy for Retinitis Pigmentosa and Other Conditions

11/29/2021

 

HOW YOUR OWN DNA COULD SOMEDAY SAVE YOUR VISION

Imagine living with a genetic disease that could cause blindness in your 40s—and your doctor tells you there are no treatment options. It's for patients like these that Johnson & Johnson is harnessing cutting-edge technology in the hope of finding real solutions.

By Hallie Levine    October 11, 2021

It can be devastating to watch someone slowly lose their vision.

Just ask James List, M.D., Ph.D., Global Therapeutic Area Head of Cardiovascular, Metabolism and Retina at Janssen Research & Development, part of the Janssen Pharmaceutical Companies of Johnson & Johnson. Before he joined the company in 2014, the Harvard endocrinologist spent his days counseling patients with diabetes. “Many people don’t realize that diabetes can cause irreversible damage to multiple organs, including the eyes,” he says.

READ MORE

Comments are closed.

    Author

    Write something about yourself. No need to be fancy, just an overview.

    Archives

    February 2023
    March 2022
    November 2021
    November 2020
    January 2018
    September 2017
    February 2017

    Categories

    All

    RSS Feed

CONTACT US

SEND APPLICATIONS TO:

Board of Directors

Mail donations to:
Eye-Link Minnesota
PO Box 43985
Minneapolis, MN 55443


Our email address is: justesen1@comcast.net
Call us: 763-561-6967
Eye-Link Minnesota
Attn:
Jeff Thompson
6835 East River Road
Fridley, MN 55432

Jim Justesen, President
Jodie H. Kalla, Secretary
Kelly McCrary, Director
Jack W. Weber, Director
Jeffrey Thompson, Director Applications
Tim Dallmann, Director Corporate/Foundation Development
Erik Jothen, Treasurer
Anne Justesen, Director Donor Development
Thomas Mason, Director Social Media

© 2023 Eye-Link Foundation. All Rights Reserved.